Lista de obras - Miriam Martini - Dominio Público Uruguay

A Novel Multiplex qRT-PCR Assay to Detect SARS-CoV-2 Infection: High Sensitivity and Increased Testing Capacity

scientific article published on 17 July 2020

BRAF V600E is a determinant of sensitivity to proteasome inhibitors

artículo científico publicado en 2013

Class II PI3K Functions in Cell Biology and Disease

artículo científico publicado en 2019

Cytokinetic Abscission: Phosphoinositides and ESCRTs Direct the Final Cut.

artículo científico publicado en 2017

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

artículo científico publicado en 2010

Erratum to: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer

scholarly article published in Targeted oncology

How PI3K-derived lipids control cell division

artículo científico publicado en 2015

Integrated molecular dissection of the epidermal growth factor receptor (EGFR) [corrected] oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.

artículo científico publicado en 2010

Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers

artículo científico publicado en 2007

Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer

artículo científico publicado en 2014

Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function

artículo científico publicado en 2017

Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis.

artículo científico publicado en 2013

Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells.

artículo científico publicado en 2013

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

artículo científico publicado en 2009

PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation

artículo científico publicado en 2021

PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts

artículo científico publicado en 2017

PI3K class II α controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function

artículo científico publicado en 2014

PI3K in cancer-stroma interactions: bad in seed and ugly in soil.

artículo científico publicado en 2013

PI3K/AKT signaling pathway and cancer: an updated review

artículo científico

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

artículo científico publicado en 2009

Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth.

artículo científico publicado en 2018

Phosphoinositides in cell proliferation and metabolism

scientific article published on 20 January 2020

Rac signal adaptation controls neutrophil mobilization from the bone marrow.

artículo científico publicado en 2016

Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses

artículo científico publicado en 2008

Signaling Pathways Regulating Redox Balance in Cancer Metabolism.

artículo científico publicado en 2018

Targeted therapies: how personal should we go?

artículo científico publicado en 2011

Targeting PI3K in Cancer: Any Good News?

artículo científico publicado en 2013

Targeting PI3K signaling in cancer: Challenges and advances

scientific article published on 01 April 2019

Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia

artículo científico publicado en 2011

The role of metabolic adaptation to nutrient stress in pancreatic cancer

artículo científico publicado en 2018

The turtle and the rabbit story in a modern (PI3)key.

artículo científico publicado en 2017

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

artículo científico publicado en 2008

Lista de obras de Miriam Martini

A Novel Multiplex qRT-PCR Assay to Detect SARS-CoV-2 Infection: High Sensitivity and Increased Testing Capacity

BRAF V600E is a determinant of sensitivity to proteasome inhibitors

Class II PI3K Functions in Cell Biology and Disease

Cytokinetic Abscission: Phosphoinositides and ESCRTs Direct the Final Cut.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

Erratum to: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer

How PI3K-derived lipids control cell division

Integrated molecular dissection of the epidermal growth factor receptor (EGFR) [corrected] oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.

Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers

Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer

Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function

Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis.

Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells.

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation

PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts

PI3K class II α controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function

PI3K in cancer-stroma interactions: bad in seed and ugly in soil.

PI3K/AKT signaling pathway and cancer: an updated review

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth.

Phosphoinositides in cell proliferation and metabolism

Rac signal adaptation controls neutrophil mobilization from the bone marrow.

Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses

Signaling Pathways Regulating Redox Balance in Cancer Metabolism.

Targeted therapies: how personal should we go?

Targeting PI3K in Cancer: Any Good News?

Targeting PI3K signaling in cancer: Challenges and advances

Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia

The role of metabolic adaptation to nutrient stress in pancreatic cancer

The turtle and the rabbit story in a modern (PI3)key.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer